Odyssean LLC Makes New $911,000 Investment in Envista Holdings Corporation $NVST

Odyssean LLC purchased a new stake in shares of Envista Holdings Corporation (NYSE:NVST) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 34,564 shares of the company’s stock, valued at approximately $911,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of NVST. Royal Bank of Canada boosted its holdings in Envista by 26.6% during the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after acquiring an additional 4,885 shares during the period. Millennium Management LLC increased its stake in Envista by 218.6% in the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock worth $6,627,000 after purchasing an additional 263,442 shares during the period. Goldman Sachs Group Inc. increased its stake in Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock worth $10,859,000 after purchasing an additional 177,630 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Envista by 15.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after purchasing an additional 76,246 shares during the last quarter. Finally, Prudential Financial Inc. lifted its position in Envista by 22.1% in the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after purchasing an additional 3,395 shares during the last quarter.

Analyst Ratings Changes

Several brokerages have recently issued reports on NVST. Zacks Research upgraded shares of Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Mizuho set a $29.00 price target on shares of Envista in a report on Thursday, August 6th. Barclays dropped their price target on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, June 11th. Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 22nd. Finally, Evercore restated an “outperform” rating and issued a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $29.31.

Insider Buying and Selling at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the transaction, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.99% of the company’s stock.

Envista Trading Up 1.1%

Shares of NVST opened at $27.76 on Thursday. The firm’s 50-day moving average price is $27.06 and its 200-day moving average price is $26.38. The firm has a market capitalization of $4.46 billion, a price-to-earnings ratio of 47.86, a PEG ratio of 1.31 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. During the same period in the prior year, the firm earned $0.26 earnings per share. Envista’s revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Sell-side analysts anticipate that Envista Holdings Corporation will post 1.53 EPS for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.